Last updated on January 2019

An Investigational Immuno-therapy Study of Nivolumab Compared to Placebo in Patients With Bladder or Upper Urinary Tract Cancer Following Surgery to Remove the Cancer


Brief description of study

The purpose of this study is to determine the effectiveness and safety of Nivolumab compared to placebo in participants who have undergone radical surgery for invasive urothelial cancer.

Clinical Study Identifier: NCT02632409

Contact Investigators or Research Sites near you

Start Over

Site 0119

Local Institution
Zerifin, Israel
  Connect »

Site 0120

Local Institution
Ramat Gan, Israel
6.25miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.